中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2014年
5期
828-829
,共2页
曲美他嗪%地尔硫卓%稳定型心绞痛%临床疗效
麯美他嗪%地爾硫卓%穩定型心絞痛%臨床療效
곡미타진%지이류탁%은정형심교통%림상료효
Trimetazidine%Diltiazem%Stable angina%Clinical efficacy
目的::探讨曲美他嗪联合地尔硫卓治疗稳定型心绞痛临床效果。方法:从我院在2012年7月到2013年7月期间收治的稳定型心绞痛患者中抽取118例进行回顾性分析,依照随机数字表的方式给予其中59例患者常规治疗(乙组),另59例患者采用曲美他嗪+地尔硫卓联合治疗(甲组),对两组的临床效果进行对比,并观察心绞痛发生情况。结果:经相应治疗,在总有效率上,甲组为91.53%(54/59),乙组为78%(46/59),甲组显著高于乙组(P<0.05);与治疗前相比,两组在治疗后的心绞痛发作次数以及持续时间上均减少,在减少幅度上,甲组要显著优于乙组(P<0.05)。结论:针对稳定型心绞痛患者,运用曲美他嗪+地尔硫卓联合治疗能够起到显著效果,可以使患者的运动耐受量得到明显改善,并使心绞痛发作次数和持续时间得到减少与降低,安全无毒副作用,值得推广。
目的::探討麯美他嗪聯閤地爾硫卓治療穩定型心絞痛臨床效果。方法:從我院在2012年7月到2013年7月期間收治的穩定型心絞痛患者中抽取118例進行迴顧性分析,依照隨機數字錶的方式給予其中59例患者常規治療(乙組),另59例患者採用麯美他嗪+地爾硫卓聯閤治療(甲組),對兩組的臨床效果進行對比,併觀察心絞痛髮生情況。結果:經相應治療,在總有效率上,甲組為91.53%(54/59),乙組為78%(46/59),甲組顯著高于乙組(P<0.05);與治療前相比,兩組在治療後的心絞痛髮作次數以及持續時間上均減少,在減少幅度上,甲組要顯著優于乙組(P<0.05)。結論:針對穩定型心絞痛患者,運用麯美他嗪+地爾硫卓聯閤治療能夠起到顯著效果,可以使患者的運動耐受量得到明顯改善,併使心絞痛髮作次數和持續時間得到減少與降低,安全無毒副作用,值得推廣。
목적::탐토곡미타진연합지이류탁치료은정형심교통림상효과。방법:종아원재2012년7월도2013년7월기간수치적은정형심교통환자중추취118례진행회고성분석,의조수궤수자표적방식급여기중59례환자상규치료(을조),령59례환자채용곡미타진+지이류탁연합치료(갑조),대량조적림상효과진행대비,병관찰심교통발생정황。결과:경상응치료,재총유효솔상,갑조위91.53%(54/59),을조위78%(46/59),갑조현저고우을조(P<0.05);여치료전상비,량조재치료후적심교통발작차수이급지속시간상균감소,재감소폭도상,갑조요현저우우을조(P<0.05)。결론:침대은정형심교통환자,운용곡미타진+지이류탁연합치료능구기도현저효과,가이사환자적운동내수량득도명현개선,병사심교통발작차수화지속시간득도감소여강저,안전무독부작용,치득추엄。
Objective:To investigate the clinical effect of trimetazidine combined with diltiazem in treatment of stable angina pectoris. Methods:118 cases selected from our hospital in treatment of stable angina pectoris were retrospectively analyzed from July 2012 to July 2013, in accordance with the manner in which the random number table, 59 patients in conventional treatment (Group B), and the other 59 cases were treated with trimetazidine+diltiazem combination therapy (Group A), the clinical effect of the two groups were compared, and observed the occurrence of angina. Results:After treatment, the total efficiency, Group A was 91.53%(54/59), Group B was 78%(46/59), Group A was significantly higher than Group B (P<0.05);former and treatment compared, both groups to reduce the number of attacks of angina after treatment and the duration on reducing the amplitude Group A was significantly better than Group B (P<0.05).Conclusion:For patients with stable angina, the use of trimetazidine+diltiazem combination therapy can play a significant effect, can make the motion tolerance of patients improved significantly, and to angina attack frequency and duration gets reduced and reduced, safe side effects, it is worth promoting.